Doug Melton, co-director of the Harvard Stem Cell Institute, says that distributing induced pluripotent stem cells to researchers around the world will advance the study of degenerative diseases like Parkinson's and diabetes. (Source: http://www.technologyreview.com/Biotech/21307/?a=f)